Intended Purpose; Indication; Intended Use; Contraindications - Pari eFlow rapid Instructions For Use Manual

Intended purpose

®
The eFlow rapid nebuliser system is
intended to administer nebuliser solutions
or suspensions as an aerosol for
inhalation.

Indication

®
The eFlow rapid nebuliser system is
indicated to administer nebuliser solutions
or suspensions approved for the treatment
of diseases of the lower airways.

Intended use

The nebuliser system must only be used
in accordance with its intended purpose.
The frequency of inhalation sessions may
vary depending on the nebuliser solutions
or suspensions and the clinical picture.
Take note of any limitations in the pack-
age leaflet accompanying the respective
nebuliser solutions or suspensions.
For reasons of hygiene and to avoid
cross-infections, the eFlow
liser handset and the connection cord
must only be used by one patient. For
patients at greater risk from infection, e.g.,
with cystic fibrosis (CF) or a weakened
immune system, or for those infected with
MRSA it is recommended that the
®
eBase Controller and the power adapter
are also used by only one patient.
Info:
®
The eBase Controller can also be
used for a medication-specific nebu-
liser handset (Tolero
®
Altera ). Follow the instructions for
use of the nebuliser handset as well.
8
®
rapid nebu-
® ®
, Zirela and
CAUTION:
Medications that are approved for inhala-
tion with a medication-specific nebuliser
handset must not be used with an
®
eFlow rapid nebuliser handset (risk of
incorrect dosage).
CAUTION:
Never attempt to inhale essential oils, as
this can cause irritation of the airways
(intense coughing).
Only original PARI accessories must be
used to operate the system (see "SPARE
PARTS AND ACCESSORIES", page 26).
CAUTION:
Using accessories and spare parts other
than those supplied by the manufacturer
may cause increased electromagnetic
emissions or reduced electromagnetic
immunity, leading to a malfunction.
PARI Pharma GmbH is not responsible
for damage if the system is used
improperly or contrary to the instructions.

Contraindications

®
For the eFlow rapid nebuliser system no
contraindication is known to
PARI Pharma GmbH. Take note of con-
traindications of the medicine in the
accompanying package leaflet.
®
eFlow rapid - 2021-04